A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia


Next in Pharmacy

Convalescent plasma is frequently administered to patients with Covid-19 and has been reported, largely on the basis of observational data, to improve clinical outcomes. Ventura A. Simonovich discusses the differences observed in clinical status between patients treated with convalescent plasma and those who received placebo.

Image courtesy of interviewee. June 23, 2021

Log-in or Sign-up to Faculti
Currently viewing this subject insight as a guest. You have insight(s) remaining for this month. Login to view 8000+ figures on the platform.
Copyright © Faculti Media Limited 2013 - 2024. All rights reserved.
error: